A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth
- 1 November 2000
- Vol. 19 (7-8) , 825-833
- https://doi.org/10.1016/s0264-410x(00)00231-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT VaccinePediatrics, 1998
- Efficacy of acellular pertussis vaccine in early childhood after household exposurePublished by American Medical Association (AMA) ,1996
- Epidemiology and control of hepatitis B infection: a perspective from the Philippines, Asia.Gut, 1996
- Overview of epidemiology and disease burden of hepatitis B in the European regionVaccine, 1995
- Haemophilus influenzae Type b Conjugate and Combination VaccinesClinical Immunotherapeutics, 1995
- Cost Benefit of Combining AntigensBiologicals, 1994
- Protective efficacy of hepatitis B vaccines in neonatesJournal of Medical Virology, 1994
- Natural History of Pertussis Antibody in the Infant and Effect on Vaccine ResponseThe Journal of Infectious Diseases, 1990
- Estimation of Corynebacterium diphtheriae antitoxin in human sera: A comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation testJournal of Medical Microbiology, 1988
- Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptideCellular Immunology, 1987